![](/img/cover-not-exists.png)
Liposomal gemcitabine (GemLip)—efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts
Peter Jantscheff, Norbert Esser, Ralph Graeser, Vittorio Ziroli, Jessica Kluth, Clemens Unger, Ulrich MassingVolume:
69
Year:
2009
Language:
english
Pages:
13
DOI:
10.1002/pros.20964
File:
PDF, 329 KB
english, 2009